Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 56

ОБЗОР2026 · pp. 59–66

Molecular and biological characteristics of tumor cells in testicular embryonal carcinoma explants

Introduction. Personalized treatment strategies for embryonal carcinoma, a germ cell tumor, are crucial due to the inherent heterogeneity of the tumor. Existing in vitro models inadequately reflect the native tumor microenvironment. Ex vivo organ culture (EVOC…

10.29296/24999490-2026-03-08Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 52–56

Comparative analysis of Hsp27 and Hsp90 expression in high- and low-grade ovarian carcinoma cells

Introduction. Ovarian cancer is characterized by high mortality. Despite available diagnostic and therapeutic methods, patient survival remains unsatisfactory, especially for high-grade tumors, necessitating the exploration of new molecular targets. Heat shock…

10.29296/24999490-2026-02-07Details ↗
ОБЗОР2025 · pp. 41–49

Blood exosomes of patients with malignant neoplasms of bones and articular cartilage: connection with tumor progression and practical value in clinical medicine

Relevance. Primary malignant neoplasms of bones and articular cartilage account for about 0.2% of all cancer cases and are characterized by an aggressive course, high tendency to metastasize, and resistance to therapy, which leads to unsatisfactory survival ra…

10.29296/24999490-2025-06-06Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 77–85

Is the progression of tuberculosis possible against the background of antitumor therapy for lung cancer? Results of an experimental study

Aim of the study. The possibility of using antitumor drugs against the background of active tuberculosis is an unresolved problem of modern medicine. The aim of the experimental study was to study the course of tuberculosis infection against the background of …

10.29296/24999490-2025-03-10Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 34–40

Efficacy of antitumor therapy schemes with carboplatin in an experimental model of lung carcinoma and drug-resistant tuberculosis

Introduction. Up to 20% of tuberculosis patients suffer from malignant neoplasms. In this case, the combination of both diseases in the lung is a particular problem. More than 60% of patients cannot complete combination therapy due to drug-resistant MBT. The a…

10.29296/24999490-2025-01-04Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 40–47

COMPARATIVE ANALYSIS OF THE DIAGNOSTIC ACCURACY OF ENDOSTATIN AND VEGF SERUM LEVELS IN PATIENTS WITH BONE SARCOMAS

Introduction. Angiogenesis regulators are of particular interest as new serum markers in cancer patients, since they reflect the intensity of tumor growth and metastasis. Currently, many works are dedicated to the study of vascular endothelial growth factor (V…

10.29296/24999490-2024-05-05Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 35–42

EFFECTIVENESS AND SAFETY OF CARBOPLATIN-CONTAINING ANTITUMOR THERAPY REGIMENS IN A MODEL OF COEXISTANCE OF LUNG CARCINOMA AND TUBERCULOSIS

Introduction. Treatment of the coexistent pathology of lung cancer and tuberculosis remains the prerogative of experimental research, since the optimal treatment strategy for the coexistence of these two diseases has not yet been developed. The purpose was to …

10.29296/24999490-2024-01-05Details ↗
ОБЗОР2024 · pp. 3–12

Immune microenvironment in hepatocellular carcinoma: current concepts and the role of blockade of immune checkpoints

Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver. The specificity of the immune microenvironment of an organ limits the possibilities of traditional therapeutic and surgical approaches to treatment, therefore one of the mo…

10.29296/24999490-2024-01-01Details ↗
ОБЗОР2023 · pp. 12–21

MOLECULAR MECHANISMS OF NEUROINFLAMMATION AND SLEEP DEPRIVATION IN THE DEVELOPMENT OF AGE-ASSOCIATED COGNITIVE DYSFUNCTION

Introduction. Proinflammatory cytokines produced in elevated concentrations in the elderly significantly impair neurogenesis in the dentate gyrus of the hippocampus, long-term potentiality, alter neuronal morphology and function, and increase apoptosis. This l…

10.29296/24999490-2023-03-02Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 25–32

THE EFFECT OF ANTITUMOR DRUGS ON THE COURSE OF TUBERCULOSIS IN THE EXPERIMENT

Introduction. Lung cancer and tuberculosis, make a significant affect to the morbidity and mortality of the population in Russia and in the world. Strategy of medication therapy has not been developed for cases when these diseases are combined. The aim of the …

10.29296/24999490-2023-02-04Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 43–49

THE EFFECT OF TUBERCULOSIS ON THE COURSE OF LUNG CARCINOMA IN THE EXPERIMENT

Introduction. One of the problems of modern medicine is the low efficiency of treatment of patients with a coexistence of lung cancer and active tuberculosis. Optimal treatment regimens for coexistence pathology have not been developed at present. In recent ye…

10.29296/24999490-2023-01-06Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 28–34

GALECTIN-3, HAPTOGLOBIN AND PROANGIOGENIC FACTORS IN GASTRIC CANCER

Introduction. Stomach cancer in Russia occupies the 4th place among most frequent malignant neoplasms, after tumors of the lung, breast and colon. The search for new diagnostic and prognostic markers of this pathology is an urgent task of modern molecular onco…

10.29296/24999490-2022-04-05Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 20–29

PROGASTRIN-RELEASING PEPTIDE (proGRP) AND NEURON SPECIFIC ENOLASE (NSE) IN SURVIVAL PROGNOSIS IN PATIENTS WITH SMALL CELL LUNG CANCER

Introduction. Small cell lung cancer (SCLS) is a highly aggressive type of tumor, and various compounds are considered as potential biochemical markers of its prognosis, including neuron-specific enolase (NSE), chromogranin A (CgA), and prograstrin releasing p…

10.29296/24999490-2022-03-03Details ↗
ОБЗОР2021

SORCIN AS A POTENTIAL TARGET IN MOLECULAR DIAGNOSTICS AND TARGETED THERAPY OF LUNG CANCER

Lung cancer occupies the leading position in at the structure of oncological morbidity in the developed countries. The overall five-year survival rate for lung cancer isn’t exceed to 10–20% even using of the entire modern arsenal of therapeutic methods. Multip…

10.29296/24999490-2021-03-01Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2020

EFFECT OF 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE DERIVATIVE ON THE COURSE OF NONALCOHOLIC FATTY LIVER DISEASE IN THE EXPERIMENT

Introduction. In the treatment of non-alcoholic fatty liver disease (NAFLD), which is the main cause of chronic liver disease, a certain role is assigned to hepatoprotectors. One of the hepatoprotectors currently used to treat NAFLD is ademetionine. At the sam…

10.29296/24999490-2020-01-04Details ↗
ОБЗОР2020

MOLECULAR MECHANISMS OF RESISTANCE DEVELOPMENT UNDER TARGETED THERAPY ON THE EXAMPLE OF CUTANEOUS MELANOMA

Cutaneous melanoma is a highly heterogeneous malignancy, which characterized by low effectiveness of chemotherapeutic antitumor agents. 50% of melanomas have a somatic mutation in BRAF oncogene, leading to uncontrolled activation of mitogen-activated protein k…

10.29296/24999490-2020-06-02Details ↗
ОБЗОР2019

PD-1 PATH: BIOLOGICAL SIGNIFICANCE, CLINICAL APPLICATION, AND EXISTING PROBLEMS

The review is devoted to the studies of immune check-point (programmed death) molecules – PD-1 receptor and its ligands PD-L1 and PD-L2, which play an important role in the regulation of immune response. Special attention is paid to soluble (s) forms of PD-1 a…

10.29296/24999490-2019-01-01Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2019

THE EFFECT OF DOCETAXEL ON THE SURVIVAL AND CLONOGENIC ACTIVITY OF MCF-7 MAMMOSPHERES CULTURE ENRICHED WITH CANCER STEM CELLS

Introduction. Cancer stem cells (CSCs), which are less sensitive to chemotherapeutic drugs than other tumor cells, play a key role in the initiation and development of the tumor process. Maintenance of CSCs determines the risk of cancer recurrence. The aim of …

10.29296/24999490-2019-05-09Details ↗

Article search and quick navigation

Navigation